Add to ORKGChronic lymphocytic leukemia (CLL) was traditionally considered as a disease of elderly patients with a generally long survival lasting up to 30 years from diagnosis. The duration and outcome of the disease is, however, highl
A retrospective cohort study was conducted among 1542 patients diagnosed with CLL between 1970 and 2...
B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable cou...
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized by the acc...
BACKGROUND AND METHODS. Specific chromosomal abnormalities have been shown to affect the overall sur...
TP53 aberrations (deletions and/or mutations, TP53ab) in chronic lymphocytic leukemia (CLL) are asso...
Chromosome analyses were performed by routine G-banding in 29 patients with B-cell chronic lymphocyt...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...
Chronic lymphocytic leukemia (CLL) represents the most prevalent leukemia in Europe and USA. CLL aff...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
Objectives: A complex karyotype (CK) is considered a poor prognostic marker in chronic lymphocytic l...
This thesis is focused on mutation status and other chromosomal changes in chronic lymphocytic leuke...
In chronic lymphocytic leukemia (CLL), chromosomes usually evade detailed cytogenetic analyses becau...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Clonal chromosome abnormalities can be detected in approximately 50% of patients with chronic lympho...
We analysed a group of 390 patients, diagnosed with chronic lymphocytic leukaemia (CLL). Cases were ...
A retrospective cohort study was conducted among 1542 patients diagnosed with CLL between 1970 and 2...
B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable cou...
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized by the acc...
BACKGROUND AND METHODS. Specific chromosomal abnormalities have been shown to affect the overall sur...
TP53 aberrations (deletions and/or mutations, TP53ab) in chronic lymphocytic leukemia (CLL) are asso...
Chromosome analyses were performed by routine G-banding in 29 patients with B-cell chronic lymphocyt...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...
Chronic lymphocytic leukemia (CLL) represents the most prevalent leukemia in Europe and USA. CLL aff...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
Objectives: A complex karyotype (CK) is considered a poor prognostic marker in chronic lymphocytic l...
This thesis is focused on mutation status and other chromosomal changes in chronic lymphocytic leuke...
In chronic lymphocytic leukemia (CLL), chromosomes usually evade detailed cytogenetic analyses becau...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Clonal chromosome abnormalities can be detected in approximately 50% of patients with chronic lympho...
We analysed a group of 390 patients, diagnosed with chronic lymphocytic leukaemia (CLL). Cases were ...
A retrospective cohort study was conducted among 1542 patients diagnosed with CLL between 1970 and 2...
B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable cou...
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized by the acc...